InvestorsHub Logo

spiky

06/28/22 10:46 PM

#419 RE: HDGabor #418

HDG,

LSVT-1701 a lysin from Roivant entering phase 2 clinical trials has been terminated for strategic reasons according to Roivant quarterly update.

Regards,
Spiky